Abstract Purpose: To isolate and identify chemical constituents with yeast α-glucosidase inhibitory activity from the methanol extract of V. myrtillus (blueberry) flowers.
INTRODUCTION
Postprandial hyperglycemia is recognized as characteristic of type 2 diabetes mellitus and plays an important role in the development of some chronic complications including circulatory disease, stroke, hypertension, blindness, kidney failure, uremia and gangrene of the lower limbs [1] . It is well known that inhibition of carbohydrate hydrolysis enzymes linked to diabetes is considered an effective approach to treat or prevent type 2 diabetes mellitus. Therefore, α-glucosidase and α-amylase are frequently used to screen therapeutic agents derived from the natural plants and isolated compounds for control of postprandial hyperglycemia [2] . Vaccinium corymbosum, also called the northern highbush blueberry, is a species of blueberry native to eastern North America. It is a deciduous shrub growing to 6 -12 feet tall and wide.
There are a great number of interests worldwide in blueberry because of its high content of beneficial constituents (such as anthocyanins, flavonols, tannins, stilbenoids and phenolic acids) and potential health benefits. Among those constituents, anthocyanins are considered to be one of the dominant blueberry polyphenols. It has been reported that blueberry extracts and its phytochemicals exhibit antioxidant [3] , α-amylase and α-glucosidase inhibitory activity [4] , anti-proliferation [5] , lipid-lowering activity [6] and cardioprotective effect [7] .
Recently blueberry fruits extracts have been shown to exhibit carbohydrate enzyme inhibitory activities but the active compounds were not identified [4] . The purpose of this study was to isolate and investigate the hypoglycemic activity compounds against inhibition of yeast α-glucosidase in vitro. 
EXPERIMENTAL

Plant material
Extraction and chromatography
The flowers (1.3 kg, fresh weight) were extracted exhaustively with MeOH (3 × 4.3 L) at room temperature to yield a dried MeOH extract (138 g). A portion of the extract (133 g) was resuspended in H 2 O (750 mL) and partitioned with EtOAc (3 × 750 mL) and n-butanol to yield a dried EtOAc extract (33 g) and n-butanol soluble fractions, respectively.
Isolation of active compounds
The EtOAc fraction (A) (32 g) was chromatographed on a C18 MPLC column (4 × 37 cm) eluting with a gradient system of MeOH/H 2 O (1:9 to 7:3, v/v) to afford 6 subfractions (A 1 -A 6 ) which were combined based on analytical HPLC analyses. Fraction A 1 (18 g) was chromatographed over a column of Sephadex LH-20 (3.5 × 120 cm) eluted with MeOH to give 5 sub-fractions (B 1 -B 5 ). Fraction B 5 was chromatographed on a C18 MPLC column (2 × 15 cm) eluting with a gradient system of MeOH/H 2 O (2:8 to 7:3, v/v) to afford 9 subfractions (C 1 -C 9 ). Fraction C 8 was separated by semi-preparative HPLC eluted with MeOH:H 2 O (61:39, v/v; 3.0 mL/min) to yield compound 1 (1.5 mg). Fraction A 5 was separated by semipreparative HPLC eluted with MeOH:H 2 O (from 4:6 to 6.5:3.5, v/v, for a period of 25 min, at a rate of 3.0 mL/min) to yield compound 2 (1.2 mg).
Yeast α-Glucosidase inhibitory assay
Yeast α-Glucosidase inhibitory activity was determined as described in the literature [10] . Briefly, a mixture of 50 μL of different concentrations of each of the samples (ethyl acetate fraction, n-buthanol fraction or two pure compounds) and 100 μL of 0.1 M phosphate buffer (pH 6.9) containing yeast α-glucosidase solution (1.0 U/ml) was incubated in 96 well plates at 25 °C for 10 min. After this preincubation period, 50 μL of 5 mM pNPG solution in 0.1 M phosphate buffer (pH 6.9) was added to each well at predetermined intervals. The reaction mixtures were incubated at 25 °C for 5 min. Absorbance was recorded at 405 nm before and after incubation with a micro-plate reader (SpectraMax M2) and compared to that of the control which had 50 μL buffer solutions instead of test samples. α-Glucosidase inhibitory activity, expressed as inhibition (%),was calculated as as in Eq 1.
Inhibition (%) = {(Ac -As)/Ac}100 ------------- (1) where Ac is the difference between the absorbance values of the control at 5 znd 0 min, and As is the difference between the absorbance values of the sample at 0 and 5 min.
Statistical analysis
All experiments were performed in triplicate. Statistical analysis of data was by Microsoft Excel XP and the results were given as mean ± standard deviation (SD). p  0.05 was considered statistically significant difference. Hz indicated a β-configuration for the glucose moiety. The trans-coumaroyl moiety was attached to the C-6 of the glucose moiety for the H-6" proton signals of the glucose moiety was shifted downfield at δ: 4.28 (1H, d, J = 11.8 Hz) and 4.20 (1H, dd, J = 11.6, 6.7 Hz), respectively. It was further confirmed by the HMBC spectrum, which showed the correlations between H-6" proton and the ester carbonyl (C-7'"). The structure of compound 1 was confirmed as isorhamnetin-3-O-(6''-O-coumaroyl)-β-D-Glucoside by comparison with published NMR data [8] . The extracts of blueberry flowers showed good α-glucosidase inhibitory activity and hence, two phenolic compounds (Figures 1 and 2) were isolated from the ethyl acetate extract. Also isorhamnetin-3-O-(6''-O-coumaroyl)-β-D-glucoside (1) was identified as an active constituent in the ethyl acetate extract of blueberry flowers. Table 1 shows the α-glucosidase inhibitory activity of the crude extracts and two isolated compounds from blueberry flowers. The ethyl acetate and n-buthanol soluble fractions showed promising α-glucosidase inhibitory activity compared with the positive control drug, acarbose. The IC 50 values of ethyl acetate and nbuthanol fractions, and acarbose were 132.7 μg/mL, 32.3 μg/mL and 129.6 μg/mL (or 200.7 μM), respectively. Although the n-buthanol fraction showed better activity than ethyl acetate fraction, HPLC chromatography (data not shown) showed that the ethyl acetate extract exhibited more detectable peaks. Therefore, further isolation was conducted on the ethyl acetate fraction.
RESULTS
α-Glucosidase inhibitory activity
The α-glucosidase inhibitory activity of the two isolated compounds was tested at the original concentration of 2 mg/mL. Compound 1 showed > 50 % inhibition activity (p  0.05), while compound 2 showed < 50 % ( p > 0.05). Hence, compound 1 was further tested and the IC 50 was calculated (Table 1) . 
DISCUSSION
Compound 1 showed better yeast α-glucosidase inhibitory activity than the positive drug acarbose (Table 1) , which was in agreement with previous reports that many flavonoids from plants have been reported as α-glucosidase inhibitors [11] . The present study also suggests that coumaroylated moiety could increase the activity of the flavonoid glycosides, which was in agreement with those concluded from the studies of acylated anthocyanins and flavonol monorhamnosides against α-glucosidase [12, 13] . 
